Check out the recap from John Roy, Ph.D.'s latest podcast with Oren Hershkovitz, CEO of Enlivex Ltd. (NASDAQ: $ENLV). Those interested can listen to the podcast on all platforms or on our website. Links are accessible in our full report! $ENLV #Enlivex# #Biotech# #Immunotherapy# #DigitalAssets# #Crypto# #Blockchain# #PredictionMarkets# #HealthcareInnovation# #ClinicalTrials# #DrugDevelopment# #Web3# #Tokenization# #SmallCapStocks# #InvestorInsights# #WaterTowerResearch# @Enlivex

Clinical trials are among the most opaque parts of modern medicine. They can be dense and difficult to understand for clinicians, let alone patients. So, @TheGutOncLab recorded an episode designed to make clinical trials a little more approachable. Not just what they are, but how patients can find, evaluate, and enroll in them. This episode is geared more toward patients than clinicians, but we hope it is helpful for anyone looking for an entry point into the world of clinical trials. Video Below: Spotify: @OncoAlert @Onco_Nexus @oncodaily @cancerGRACE

How accurate are clinical trials of varicella (chickenpox) #vaccines#? The CDC states that “Prelicensure trials are relatively small – usually limited to a few thousand subjects – and usually last no longer than a few years.” #protectyourkids# Find out more:

NewLimit CEO @jacobkimmel explains the clinical trial bottleneck AI can't fix: biology has irreducible latency "It's unlikely we're gonna see rapid expedition of clinical trials because a lot of the periods of time can't be expedited based on the biological primitives. In computer science you often have a notion of bandwidth and latency." "There are some irreducible latencies in clinical trials. If you wanna give a drug to a patient and see if they're healthy a month later, it's not like you can enroll 30 patients and check back in one day. You just need to wait a full month. The classic nine people can't have a baby in one month story." "The other thing we can hope for is that the success rate might improve. Right now, rough math, roughly 9 out of 10 drugs that go into the clinic will ultimately fail." "If you're able to even just 2X that success rate, getting to 20% success rather than 10%, then you would double the number of drugs that come out every year, and you would cut the effective cost in half." @newlimit

Protect your health: retatrutide is being studied in clinical trials and hasn’t been approved for sale to consumers. You don’t know what’s in black-market unapproved “reta.” Don’t take the risk. Learn more: